Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from BioNTech

Why Is AbbVie Stock Trading Higher On Thursday?

IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation Inc., and AbbVie Inc. (NYSE:ABBV), on Thursday, announced an exclusive licensing agreement for IGI’s lead investigational asset, ISB 2001, developed using IGI’s proprietary BEAT protein platform, for oncology and autoimmune diseases.

Benzinga

Is BioNTech Stock a Buy on Major $11 Billion Cancer-Drug Deal?

With BioNTech sealing a blockbuster $11 billion cancer deal with Bristol-Myers Squibb, should investors be loading up on this rising biotech star?

Barchart

Dow Jones Falls On U.S.-China Tensions, Economic Data; Nucor Jumps As Tesla, Palantir Slide

The Dow Jones fell modestly Monday amid U.S.-China tensions. Palantir and Tesla moved near buy points. Nucor jumped on Trump tariffs.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

The FDA Is Limiting Covid Shots. But Moderna, Vaccine Stocks Jumped.

The FDA said Tuesday it will limit future Covid vaccines to older and at-risk Americans. The move buoyed Moderna, BioNTech and Novavax.

Investors Business Daily

Vaccine maker’s £1bn UK investment to create ‘hundreds of high-skilled jobs’

BioNTech developed mRNA vaccines, and cancer immunotherapies notably used to tackle Covid-19.

Evening Standard

BioNTech Surges On Summit's Coattails. But Can They Take On Merck?

BioNTech stock rocketed Wednesday after rival Summit Therapeutics unveiled promising results for a novel approach to lung cancer treatment.

Investors Business Daily

Why Moderna Stock Has Surged 15% This Week Despite Mixed News

Moderna stock has surged more than 20% this week after regulatory filings showed several executives bought shares on the open market.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike

Moderna stock surged Tuesday after the Centers for Disease Control and Prevention noted a two-week spike in positive Covid tests.

Investors Business Daily

Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy

Pfizer stock is setting up for a wild ride in 2025 as it faces off with an activist and Robert F. Kennedy Jr. as the possible HHS lead.

Investors Business Daily

Why Is BioNTech Stock Trading Higher On Friday?

BNT324/DB-1311 trial data show significant antitumor activity in various cancers, with high response rates in small cell lung and prostate cancer patients.

Benzinga

US inflation rises to 2.6% in October; Post Office closures put 2,000 jobs at risk – as it happened

Inflation figures closely watched by US Federal Reserve; core inflation holds steady at 3.3%

The Guardian - UK

BioNTech Nears A Sell Signal After Cutting Outlook Despite Massive Sales Beat

BioNTech stock reversed lower Monday after the company cut its outlook for the year, despite walloping sales estimates.

Investors Business Daily

As Stock Market Awaits Election, Palantir, S&P 500 Nuke Leaders Report

Amid the election, and a Fed rate vote, earnings season roars ahead.

Investors Business Daily

How BioNTech, Up 26% Over Four Days, Is Riding Summit's Coattails To A Recovery

BioNTech stock has climbed 26% over four days as the German biotech rides a round of cancer treatment success from Summit Therapeutics.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Al Jazeera

Mpox crisis: Why do African countries struggle to make or buy vaccines?

African countries produce less than 2 percent of the vaccines the continent needs, experts say.

The Guardian - UK

World-first lung cancer vaccine trials launched across seven countries

First patient in UK gets dose of jab designed to kill most common form of lung cancer – and stop it coming back

The Independent UK

Lung cancer vaccine: Breakthrough jab could improve survival rates

The vaccine, known as BNT116, utilises messenger RNA (mRNA), the same technology used in the Covid jab

The Independent UK

Lung cancer vaccine: How does it work?

The first UK patient received the jab at the National Institute for Health Research UCLH Clinical Research Facility on Tuesday.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Pfizer Slides Toward Sell Zone After BioNTech-Tied Covid/Flu Shot Misses Its Mark

Pfizer stock toppled Friday after the pharma giant reported mixed results for its BioNTech-partnered combination flu and Covid vaccine.

The Guardian - UK

NHS patients in England to be offered trials for world-first cancer vaccine

Jab personalised for individual’s tumours hailed as ‘gamechanger’ amid high hopes of stopping disease returning

Kiplinger

The Fight Against Cancer Enters a New Phase

Breakthrough treatments hold promise for patients and investors.

Investors Business Daily

BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come

BioNTech stock lifted a fraction Monday after Covid vaccine sales dropped again in the first quarter, amid wide losses.

International Business Times

InstaDeep CEO Takes AI From Tunis To London

Karim Beguir launched the artificial intelligence start-up InstaDeep in Tunisia in 2014 with just two computers and $2,000.